
|Articles|July 28, 2021
Supplements and Featured Publications
- Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease
Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease
Advertisement
This AJMC® Profiles in Care provides an in-depth look into the results of the innovative outcomes-based agreement between Boehringer Ingelheim and Highmark Inc that focused on total cost of care for patients with type 2 diabetes and cardiovascular disease. An overview of the results, as well as valuable insights from experts from Boehringer Ingelheim and Highmark, are included.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MD
5














































